An Liangliang, Gaowa Sharen, Cheng Haidong, Hou Mingxing
Department of General Surgery, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
Department of Pathology, College of Basic Medicine, Inner Mongolia Medical University, Hohhot, China.
Front Oncol. 2019 Aug 7;9:725. doi: 10.3389/fonc.2019.00725. eCollection 2019.
Endoscopic resection (ER) and gastrectomy have been both accepted as curative treatments for early gastric cancer. We intended to compare ER with gastrectomy treatments on safety of patients, disease-free survival and overall survival for early gastric cancer through this systematic review. A literature search was performed in Pubmed, Embase, and Cochrane Library databases. Studies that have compared ER with gastrectomy for early gastric cancer were included in this meta-analysis. We searched for clinical studies published before March 2019. Stata 12.0 software was used for systematic analysis. Nine studies were included in this systematic review, ER treatment was associated with a shorter length of stay (WMD = -8.53, 95% CI -11.56 to -5.49), fewer postoperative complications (OR = 0.47, 95% CI 0.34-0.65). ER can be performed safely with shorter hospital stay and fewer postoperative complications than gastrectomy. Recurrence rate was higher for ER than for gastrectomy treatment (HR = 3.56, 95% CI 1.86-6.84), mainly because metachronous gastric cancers developed only in the ER treatment. However, most of the metachronous gastric cancers could be curatively treated with ER again, and it didn't affect overall survival of patients with early gastric cancer. There was no difference in overall survival rate between ER and gastrectomy (HR = 0.84, 95% CI 0.63-1.13). ER and gastrectomy are both acceptable for curative treatment of early gastric cancer. However, due to the comparable overall survival and lower postoperative complications and shorter length of stay, ER is better than gastrectomy for early gastric cancer, who met the indication for ER treatment.
内镜切除术(ER)和胃切除术均被视为早期胃癌的根治性治疗方法。我们旨在通过这项系统评价,比较ER与胃切除术在早期胃癌患者安全性、无病生存率和总生存率方面的差异。在PubMed、Embase和Cochrane图书馆数据库中进行了文献检索。将比较ER与胃切除术治疗早期胃癌的研究纳入该荟萃分析。我们检索了2019年3月之前发表的临床研究。使用Stata 12.0软件进行系统分析。该系统评价纳入了9项研究,ER治疗与住院时间缩短相关(加权均数差=-8.53,95%可信区间-11.56至-5.49),术后并发症较少(比值比=0.47,95%可信区间0.34-0.65)。与胃切除术相比,ER可以安全实施,住院时间更短,术后并发症更少。ER的复发率高于胃切除术治疗(风险比=3.56,95%可信区间1.86-6.84),主要是因为异时性胃癌仅在ER治疗中发生。然而,大多数异时性胃癌可以再次通过ER进行根治性治疗,且不影响早期胃癌患者的总生存率。ER和胃切除术的总生存率没有差异(风险比=0.84,95%可信区间0.63-1.13)。ER和胃切除术均适用于早期胃癌的根治性治疗。然而,由于总生存率相当,术后并发症较少且住院时间较短,对于符合ER治疗指征的早期胃癌患者,ER优于胃切除术。